A case of small vessel vasculitis(HSP) presenting with recurrent abdominal pain

Dr. Sandeep Kumar Reddy

Speaker Name: Dr. Sandeep Kumar Reddy
Category: (Speaker/Oral Presentation)

Biography: Madras medical college TNMGRU Chennai

Global Journal of Gastroenterology & Hepatology Research [GJGHR]

ABSTRACT:

Henoch–Schönlein purpura (HSP), also known as IgA vasculitis, is a systemic vasculitis which is the most common vasculitis in children.

The incidence in adults varies from 3.4 to 14.3 cases per million.
The classic triad of symptoms include purpuric rash, arthritis and abdominal pain.

KEY WORDS: small vessel vasculitis;rash;abdominal pain.

We present a case of a 45 year-old female with HSP who presented with recurrent episodes of abdominal pain, followed by classical symptoms with an identified post-infectious etiology.

A 45 year old female with no previous  medical history presented with  a florid purpuric rash  affecting distal  extremities, abdominal  pain and a monoarthritis of her wrist.

Two weeks prior she  had attended casualty with  a flu-like  illness and a swollen tender  right ankle, but subsequently discharged without workup.

Over  the course  of next week she  began to develop a purpuric rash  on  her distal  extremities spreading to  buttocks .On presentation  she  developed central crampy abdominal  pain, increasing  in severity  over  the previous  2 days with  no  relief  with simple  analgesics.

On  initial examination her right wrist was swollen and tender  on  palpation.  She remained afebrile with  temperature of 37celsius and  B.P 128/80 mmHg, heart rate of 78 bpm and oxygen saturation of 98% on room air.

No other obvious infective sources were  identified  on  initial examination with  no  evidence of meningism.

Inflammatory  markers were  raised  with  a white cell  count of 12.8  ×  10 9 /L  and C-reactive protein of 48.6 mg/L. Coagulation profile was normal  with  platelet count 442 ×  10 9 /L. ESR was elevated  at  48 mm/h.

Urinalysis revealed  a trace of protein.
Diagnosis and initial management

A working diagnosis of Henoch–Schönlein purpura (HSP) was made and she was started on  oral  prednisolone  along with protein pump  inhibitor (PPI). Further investigations  sent included immunoglobulin (Ig)  profile, complement level and albumin creatinine  ratio.

Anti-streptolysin O titre was sent as  the patient had sore throat two weeks before.On day two of admission the purpuric rash  was less  pronounced, and serum Ig levels revealed an elevated IgA of 5.40 g/L (0.8–2.8 g/L)

CECT abdomen-Diffuse circumferential regular wall thickening in antro-pyloric region p/o Gastritis.

Ogd showed-Diffusely inflammed stomach with erosions.multiple tiny ulcers in duodenum with nodularity.Biopsy-Active duodenitis.

Skin biopsy showed :flaky inflammatory infiltrate around blood vessels.Fibrinoid degeneration of vessel wall seen.No thrombosis inside tubular blood vessels.

Inflammatory infiltrate consists of mononuclear cells, lymphocytes around hair follicles.Impression: Features suggestive of cutaneous small vessel vasculitis.

Over  the next  24  hours  she  began to experience abdominal pain and vomiting  with  increasing  severity  requiring opioid analgesia.  On  examination there was an  improvement in purpuric rash, and the abdomen was soft with no guarding or rebound tenderness  and bowel sounds  were  heard.  Arterial  blood  gas revealed a metabolic alkalosis with pH 7.53, bicarbonate (HCO 3 ) standard 29.7  mmol/L  and lactate 2.2 mmol/L. Abdominal  film showed  non-specific gas pattern with  no  obvious perforation or obstruction.  Full  blood  picture showed  a rise  in white cell  count to 21.4  ×10 9 /L  with  a prominent neutrophilia.

In view of gastrointestinal  (GI) haemorrhage and bowel wall  oedema  associated  with  the condition,  treatment was changed to course  of intravenous (IV) methylprednisolone  with  IV  PPI cover.The patient’s abdominal  pain and vomiting  subsequently improved  with  a combination treatment of 3 days  IV methylprednisolone, IV  fluids and antiemetics.  Five days  after initial presentation, purpuric rash  had resolved  along with  right wrist monoarthritis.  Prior to discharge anti-streptolysin O titre elevated at 400 IU/L and a diagnosis of HSP precipitated by streptococci  infection was made. She  was subsequently discharged on  a slow  tapering  dose  of oral  prednisolone, and reviewed  in opd 8 weeks post-admission  with  a complete resolution  of symptoms.

Discussion:

HSP is a small vessel vasculitis in which immune  complexes of IgA and complement component 3 (c3)  are deposited on  capillaries, venules and arterioles. In adults, HSP has been observed to have a higher  frequency of systemic involvement and the outcome in adults was found to be  similar to children  with  complete recovery from the disease in the majority of cases.   The typical symptoms include  purpuric rash  appearing on  legs  and buttocks  however the rash may also be seen on the arms, face and trunk. Joint arthritis involves ankles, knees and elbows and is non-erosive hence does not cause permanent deformity.40% of patients will have renal involvement,  mainly in the form  of haematuria  which is predominantly microscopic in nature.

Proteinuria occurs  in more than  half  of patients  involved, some  of which is severe  enough  to cause nephrotic syndrome. Approximately 1% of all HSP patients go on to develop chronic kidney disease, and adults are more likely to do  so  than  children.  Clinically, since there are no  disease-specific laboratory abnormalities,  HSP is currently diagnosed based on  symptoms,signs and histopathology.

To date, several diagnostic criteria  have been  proposed  with  the most  recent gold standard EULAR/PRINTO/PRES criteria  2010.GI symptoms occur in about one half of HSP patients and range from  mild  symptoms  to more  significant conditions  such as  intussusception ,GI haemorrhage, bowel ischaemia and perforation.In a study involving HSP in the adult  population, 24.1% of patients  developed GI symptoms  prior to the cutaneous rash.  Abdominal  pain is typically colicky in nature, poorly localized, and can be  accompanied with  vomiting  and bloody diarrhoea.

Treatment remains primarily supportive in most  cases and hospitalisation should  be  considered  for patients  with  severe abdominal  pain, significant GI bleeding or  marked  renal insufficiency.

Supportive measures  include  adequate hydration and monitoring  for abdominal  and renal sequelae. Any unnecessary drugs should be discontinued if a drug-related aetiology is being considered.

Drugs associated with development of HSP include antibiotics such  as  vancomycin, cefuroxime, ACE inhibitors  and diclofenac.More  than  75% of patients  report  prior history of upper respiratory  tract  or  pharyngeal  infection.    The development of HSP has been associated  with multiple  bacterial and viral infectious agents.

Examples  include  group A streptococcal infection, mycoplasma,  hepatitis B and herpes  simplex virus.

Due to the high  spontaneous recovery  rate most  patients  do not require specific therapy and steroids are generally avoided.

Steroids  may shorten the duration  of abdominal  and joint pain but must  be  weighed up  against potential adverse effects.  Abdominal symptoms  in HSP are caused  by  haemorrhage and oedema  within the bowel wall  and mesentery.  The pathophysiology of steroid use for GI may be  attributed  to the reduction edema.

References:   

1)Blanco    R   ,     Martínez-Taboada    VM   ,     Rodríguez-Valverde    V   ,     GarcíaFuentes    M   ,     González-Gay    MA   .   Henoch–Schönlein  purpura  in adulthood and childhood: two different expressions of the same syndrome .   Arthritis and Rheumatism 1997

2)Srestha    S   ,     Sumingan    N   ,     Tan    J      et al   .   Henoch–Schönlein  purpura with nephritis in adults: adverse prognostic indicators in a UK  population .   QJM 2006 ; 99 : 253 – 65 .        Ozen    S   ,     Pistorio    A   ,     Iusan    SM      et al   .   EULAR/PRINTO/PRES  criteria  for Henoch–Schönlein purpura

3)Zhang    Y   ,     Huang    X   .   Gastrointestinal  involvement  in  HenochSchönlein purpura .   Scand J Gastroenterol 2008 ; 43 : 1038 – 43 .

4)Rigante    D   ,     Castellazzi    L   ,     Bosco    A   ,     Esposito    S   .   Is  there  a  crossroad between infections, genetics, and Henoch–Schönlein purpura?  Autoimmun Rev 2013 ; 12 : 1016 – 21 .

Tags

Crohn’s and Colitis Journals | Gastroenterology & Hepatology Journals | Gastroenterology Journals | Research Gastroenterology and Hepatology Journals | Clinical and Experimental Gastroenterology Journals | Gastrointestinal Endoscopy Journals | Therapeutic Advances in Gastroenterology Journals | Colorectal Disease: clinical and molecular gastroenterology and surgery Journals | Inflammatory Bowel Diseases Journals | Expert Review of Gastroenterology & Hepatology Journals | Clinical Colorectal Journals | Cancer Gut Journals | Endoscopy Journals | Hepatitis B Annual Journals | Hepato-biliary-Pancreatic Sciences Journals | Medical Bulletin Journals 

Upcoming Conference:

World Gastroenterology, IBD, Hepatology Conference & Exhibition
Visit here: https://gastroenterology.utilitarianconferences.com/
Submit your abstract/research paper here: https://gastroenterology.utilitarianconferences.com/submit-abstract
Attend as a Speaker/Poster/Delegate In-person kindly register here: https://gastroenterology.utilitarianconferences.com/registration
Attend as a Speaker/Poster/Delegate virtually kindly register: https://gastroenterology.utilitarianconferences.com/virtual-registration

Exit mobile version